Skip to main content
Premium Trial:

Request an Annual Quote

ABI Reports Increased Revenues for 4th Quarter

Click herefor an updated version of this story.

 

NEW YORK, July 23 - Applied Biosystems of Applera this morning reported net revenues of $432.9 million for the fourth quarter ending June 30, up over $417 million for the same quarter of 2002, the Foster City, Calif.-based company said in a statement.

 

The company reported net income of $96.1 million for the quarter, compared to $38.2 million for the year-ago period.

 

The company recorded research and development charges of $58.2 million, compared to $58.0 million for the same quarter in 2002.

 

"In light of the challenging business environment, I am pleased that Applied Biosystems achieved solid earnings growth and strong cash flow from operations during the fourth quarter," said Michael Hunkapiller, president, ABI, said in a statement.

 

The company on Tuesday said that it plans to launch a whole-genome microarray product.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.